Evidence supporting the use of: L-carnitine
For the health condition: Heart (weakness)

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

L-carnitine for Heart Weakness: Evidence Overview

L-carnitine is a naturally occurring amino acid derivative that plays a critical role in energy production by transporting fatty acids into the mitochondria, where they are oxidized for energy. Its use in supporting heart function—particularly in cases of heart failure ("heart weakness")—is backed by a moderate level of scientific evidence.

Several clinical studies and meta-analyses have investigated L-carnitine supplementation in patients with chronic heart failure. Some randomized controlled trials have demonstrated improvements in cardiac function, exercise capacity, and symptoms in these patients. For example, a 2013 meta-analysis published in the journal Heart Failure Reviews found that L-carnitine supplementation was associated with improved left ventricular ejection fraction, reduced mortality, and improved exercise tolerance in patients with chronic heart failure.

The proposed mechanism involves enhanced fatty acid oxidation and energy production in the myocardium, which is often compromised in heart failure. Additionally, L-carnitine may exert anti-ischemic and anti-oxidative effects, further supporting heart health.

However, while results are promising, larger and more rigorous trials are needed to confirm these benefits and establish optimal dosing. Major clinical guidelines do not yet universally recommend L-carnitine for heart failure, but it is sometimes used as adjunctive therapy, especially in specific cases such as primary or secondary carnitine deficiency.

In summary, there is scientific support—though not yet conclusive—for the use of L-carnitine as a supplement in the management of heart weakness.

More about l-carnitine
More about Heart (weakness)